The General Insurance Council has defended its fever admission advisory framework, emphasizing that the guidelines are based on Indian Council of Medical Research (ICMR) and Ministry of Health and Family Welfare (MoHFW) guidelines rather than independent medical standards. According to Business Standard, S Prakash, CEO of Health Insurance Ecosystem and Strategic Partnerships at GIC, stated that the advisory was developed in response to a rise in avoidable hospital admissions and misuse of health insurance coverage, not as an attempt to interfere with doctors' decision-making. The council clarified that it has not created independent medical standards but has aligned insurance practices with existing government-backed healthcare frameworks, ensuring insurance coverage reinforces national health policy rather than deviating from it. The advisory cites recommendations from the Indian Medical Association (IMA), Indian Council of Medical Research (ICMR), World Health Organisation (WHO), National Health Mission (NHM) and Union health ministry.
Dr S Prakash told The Times of India that the document is purely advisory and that clinical judgement continues to be respected, explaining that the advisory aims to avoid scenarios where patients are admitted on the first day of high fever when confirmatory tests can only be done on the third day. However, the medical community expresses significant concerns about potential claim denials. Dr Sudhir Naik, trustee of the Association of Medical Consultants and a nursing home owner, warned that the document could become a weapon for insurance companies to deny claims, with the worst affected being patients at smaller hospitals without negotiating power. An industry executive cited by The Times of India said reducing fraud, abuse, and wastage was necessary to keep health insurance affordable, since claims have to be paid out of premiums collected. The guidelines have generated particular concern among smaller hospitals, who worry that the document could increase disputes between insurers and healthcare providers, placing additional financial pressure on institutions that depend on timely claim settlements.
According to Business Standard, health claims settled by insurers reached ₹94,247.6 crore in 2024-25, with cashless admissions accounting for 66.4 per cent of the volume. The council has observed a significant increase in claims involving admissions for minor fever cases, unnecessary investigations and prolonged hospital stays that do not align with established clinical practices. Such trends increase healthcare costs and contribute to rising insurance premiums for policyholders, with the council noting that unnecessary admissions can expose patients to additional risks including hospital-acquired infections, medication-related complications and avoidable financial burden. The move comes at a time when insurers continue to witness a surge in claims during the monsoon season, when infectious diseases typically peak across the country.
Gautam Khanna, CEO of Hinduja Hospital and president of the Association of Hospitals, described the document as advisory rather than mandatory, telling The Times of India that individual hospitals retain the choice of whether to follow it. As reported by Business Standard, the council stressed that doctors would continue to have the authority to admit patients whenever medically justified, with the ability to deviate from advisory pathways through appropriate clinical documentation and accountability. The advisory sets specific criteria for conditions including viral fever, pneumonia, and acute gastroenteritis, recommending hospitalisation only where patients show warning signs such as persistent high fever, breathing difficulty, dehydration, altered consciousness, organ dysfunction, or other serious complications. The council has invited feedback from doctors, hospitals and medical associations, provided such inputs are supported by clinical evidence, with its objective being to create a sustainable health insurance ecosystem that balances patient protection, affordability of insurance coverage and evidence-based medical care.
